Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB - Nasdaq - US7194051022 - Common Stock - Currency: USD

19.49  -0.39 (-1.96%)

After market: 19.49 0 (0%)

Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making PLAB a very profitable company, without any liquidiy or solvency issues. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make PLAB a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
In the past year PLAB had a positive cash flow from operations.
In the past 5 years PLAB has always been profitable.
Each year in the past 5 years PLAB had a positive operating cash flow.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

PLAB has a better Return On Assets (7.04%) than 73.64% of its industry peers.
The Return On Equity of PLAB (10.90%) is better than 70.00% of its industry peers.
PLAB has a Return On Invested Capital of 10.42%. This is in the better half of the industry: PLAB outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PLAB is above the industry average of 10.58%.
Industry RankSector Rank
ROA 7.04%
ROE 10.9%
ROIC 10.42%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

With a decent Profit Margin value of 14.00%, PLAB is doing good in the industry, outperforming 71.82% of the companies in the same industry.
PLAB's Profit Margin has improved in the last couple of years.
PLAB has a better Operating Margin (25.20%) than 84.55% of its industry peers.
PLAB's Operating Margin has improved in the last couple of years.
PLAB has a Gross Margin of 36.29%. This is in the lower half of the industry: PLAB underperforms 64.55% of its industry peers.
PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.2%
PM (TTM) 14%
GM 36.29%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PLAB is creating some value.
The number of shares outstanding for PLAB has been increased compared to 1 year ago.
The number of shares outstanding for PLAB has been reduced compared to 5 years ago.
Compared to 1 year ago, PLAB has an improved debt to assets ratio.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

PLAB has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
PLAB's Debt to FCF ratio of 0.00 is amongst the best of the industry. PLAB outperforms 84.55% of its industry peers.
PLAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PLAB (0.00) is better than 71.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.9
WACC11.55%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PLAB has a Current Ratio of 5.13. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
PLAB has a Current ratio of 5.13. This is in the better half of the industry: PLAB outperforms 74.55% of its industry peers.
A Quick Ratio of 4.76 indicates that PLAB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.76, PLAB belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.13
Quick Ratio 4.76
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

PLAB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.98%.
The Earnings Per Share has been growing by 33.90% on average over the past years. This is a very strong growth
Looking at the last year, PLAB shows a decrease in Revenue. The Revenue has decreased by -3.19% in the last year.
PLAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.50% yearly.
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%

3.2 Future

The Earnings Per Share is expected to grow by 1.07% on average over the next years.
Based on estimates for the next years, PLAB will show a small growth in Revenue. The Revenue will grow by 0.93% on average per year.
EPS Next Y-11.62%
EPS Next 2Y1.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.04%
Revenue Next 2Y0.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.65, the valuation of PLAB can be described as reasonable.
Based on the Price/Earnings ratio, PLAB is valued cheaply inside the industry as 97.27% of the companies are valued more expensively.
PLAB is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.64, the valuation of PLAB can be described as very reasonable.
PLAB's Price/Forward Earnings ratio is rather cheap when compared to the industry. PLAB is cheaper than 98.18% of the companies in the same industry.
PLAB is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.65
Fwd PE 9.64
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

99.09% of the companies in the same industry are more expensive than PLAB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PLAB is valued cheaper than 95.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.05
EV/EBITDA 1.97
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.28
EPS Next 2Y1.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (7/11/2025, 8:00:00 PM)

After market: 19.49 0 (0%)

19.49

-0.39 (-1.96%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-28 2025-05-28/bmo
Earnings (Next)08-27 2025-08-27/bmo
Inst Owners90.34%
Inst Owner Change0%
Ins Owners3.77%
Ins Owner Change5.39%
Market Cap1.17B
Analysts84.44
Price Target31.84 (63.37%)
Short Float %5.21%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.34%
Min EPS beat(2)-19.14%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-2.54%
Min EPS beat(4)-19.14%
Max EPS beat(4)11.24%
EPS beat(8)3
Avg EPS beat(8)-3.56%
EPS beat(12)5
Avg EPS beat(12)-0.54%
EPS beat(16)9
Avg EPS beat(16)5.15%
Revenue beat(2)0
Avg Revenue beat(2)-1.71%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-2.84%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)1
Avg Revenue beat(8)-3.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.45%
Revenue beat(16)7
Avg Revenue beat(16)-0.66%
PT rev (1m)-5.4%
PT rev (3m)-12.07%
EPS NQ rev (1m)-16.46%
EPS NQ rev (3m)-24.07%
EPS NY rev (1m)-15.9%
EPS NY rev (3m)-14.22%
Revenue NQ rev (1m)-3.61%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-2.11%
Revenue NY rev (3m)-4.13%
Valuation
Industry RankSector Rank
PE 9.65
Fwd PE 9.64
P/S 1.37
P/FCF 13.05
P/OCF 4.63
P/B 1.06
P/tB 1.06
EV/EBITDA 1.97
EPS(TTM)2.02
EY10.36%
EPS(NY)2.02
Fwd EY10.38%
FCF(TTM)1.49
FCFY7.66%
OCF(TTM)4.21
OCFY21.61%
SpS14.24
BVpS18.3
TBVpS18.3
PEG (NY)N/A
PEG (5Y)0.28
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 10.9%
ROCE 14.05%
ROIC 10.42%
ROICexc 16.37%
ROICexgc 16.37%
OM 25.2%
PM (TTM) 14%
GM 36.29%
FCFM 10.49%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 200.14%
Cap/Sales 19.09%
Interest Coverage 250
Cash Conversion 85.14%
Profit Quality 74.89%
Current Ratio 5.13
Quick Ratio 4.76
Altman-Z N/A
F-Score5
WACC11.55%
ROIC/WACC0.9
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
EPS Next Y-11.62%
EPS Next 2Y1.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%
Revenue Next Year-3.04%
Revenue Next 2Y0.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.39%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year34.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.59%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-10.03%
OCF growth 3Y20.13%
OCF growth 5Y30.76%